Expression of Foxp3 mRNA in hepatocellular carcinoma peripheral blood and effect of TACE on its expression

XIAO Qi,XIAO Jian-sheng,CAI Jun,WU Hua-wen,ZENG Lin-shan

2013-01-01

Abstract:【Objective】 To explore hepatocellular carcinoma patients peripheral blood mononuclear cells Foxp3 mRNA expression amount of change.【Methods】 Peripheral blood samples of 30 cases of HCC patients before TACE chemotherapy,after chemotherapy one week later,14 cases of healthy people and 14 cases of patients with chronic hepatitis B were collected.Detected the Foxp3 mRNA expression by RT-PCR with GAPDH as an internal reference.【Results】 Foxp3 mRNA expression difference was statistically significant among the healthy people control group,the chronic hepatitis B group and before TACE chemotherapy group(P <0.01);Foxp3 mRNA expression level in healthy people was lower than chronic hepatitis B group and before TACE chemotherapy group,the difference was statistically significant(P <0.01);Foxp3 mRNA expression level in chronic hepatitis B group was lower than before TACE chemotherapy group,the difference was statistically significant(P <0.01);Foxp3 mRNA expression level decreased in HCC patients after TACE chemotherapy,the difference was statistically significant(t =48.3,P <0.01).【Conclusion】 Foxp3 mRNA expression in peripheral blood mononuclear cells in HCC patients was higher than in patients withchronichepatitis B and healthy people.Foxp3 mRNA expression of change relate to the occurrence and development of liver cancer.Foxp3 mRNA expression level decreased in HCC patients after TACE chemotherapy,it shows that TACE affect liver cancer patients immune function.